Cargando…
Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
With inconsistent findings, evidence has been obtained in recent years that metabolic disorders are closely associated with the development of lymphomas. Studies and multiple analyses have been published also indicating that some solid tumor survivors develop a secondary lymphoma, whereas some lymph...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917635/ https://www.ncbi.nlm.nih.gov/pubmed/35279210 http://dx.doi.org/10.1186/s13578-022-00763-0 |
_version_ | 1784668591047573504 |
---|---|
author | Yu, Youxi Shi, Xiaoju Wang, Xingtong Zhang, Ping Bai, Ou Li, Yan |
author_facet | Yu, Youxi Shi, Xiaoju Wang, Xingtong Zhang, Ping Bai, Ou Li, Yan |
author_sort | Yu, Youxi |
collection | PubMed |
description | With inconsistent findings, evidence has been obtained in recent years that metabolic disorders are closely associated with the development of lymphomas. Studies and multiple analyses have been published also indicating that some solid tumor survivors develop a secondary lymphoma, whereas some lymphoma survivors subsequently develop a second malignant neoplasm (SMN), particularly solid tumors. An interaction between the multiple etiologic factors such as genetic factors and late effects of cancer therapy may play an important role contributing to the carcinogenesis in patients with metabolic diseases or with a primary cancer. In this review, we summarize the current knowledge of the multiple etiologic factors for lymphomagenesis, focusing on the SMN in lymphoma, secondary lymphomas in primary cancers, and the lymphomas associated to metabolic disorders/diseases, which have been received less attention previously. Further, we also review the data of coexistence of lymphomas and hepatocellular carcinoma (HCC) in patients with infection of hepatitis C virus and hepatitis B virus. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8917635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89176352022-03-21 Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases Yu, Youxi Shi, Xiaoju Wang, Xingtong Zhang, Ping Bai, Ou Li, Yan Cell Biosci Review With inconsistent findings, evidence has been obtained in recent years that metabolic disorders are closely associated with the development of lymphomas. Studies and multiple analyses have been published also indicating that some solid tumor survivors develop a secondary lymphoma, whereas some lymphoma survivors subsequently develop a second malignant neoplasm (SMN), particularly solid tumors. An interaction between the multiple etiologic factors such as genetic factors and late effects of cancer therapy may play an important role contributing to the carcinogenesis in patients with metabolic diseases or with a primary cancer. In this review, we summarize the current knowledge of the multiple etiologic factors for lymphomagenesis, focusing on the SMN in lymphoma, secondary lymphomas in primary cancers, and the lymphomas associated to metabolic disorders/diseases, which have been received less attention previously. Further, we also review the data of coexistence of lymphomas and hepatocellular carcinoma (HCC) in patients with infection of hepatitis C virus and hepatitis B virus. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-03-12 /pmc/articles/PMC8917635/ /pubmed/35279210 http://dx.doi.org/10.1186/s13578-022-00763-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Yu, Youxi Shi, Xiaoju Wang, Xingtong Zhang, Ping Bai, Ou Li, Yan Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
title | Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
title_full | Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
title_fullStr | Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
title_full_unstemmed | Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
title_short | Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
title_sort | second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917635/ https://www.ncbi.nlm.nih.gov/pubmed/35279210 http://dx.doi.org/10.1186/s13578-022-00763-0 |
work_keys_str_mv | AT yuyouxi secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases AT shixiaoju secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases AT wangxingtong secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases AT zhangping secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases AT baiou secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases AT liyan secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases |